A promising medication , retatrutide, is generating considerable excitement within the Oz weight control community. Designed by Eli Lilly , this combination GIP and GLP-1 receptor appears to deliver more substantial benefits than existing therapies. Preliminary clinical trials have shown remarkable reductions in overall weight , indicating the f… Read More